502 reports of this reaction
5.2% of all NUSINERSEN reports
#2 most reported adverse reaction
POST LUMBAR PUNCTURE SYNDROME is the #2 most commonly reported adverse reaction for NUSINERSEN. There are 502 FDA adverse event reports linking NUSINERSEN to POST LUMBAR PUNCTURE SYNDROME. This represents approximately 5.2% of all 9,682 adverse event reports for this drug.
Patients taking NUSINERSEN who experience post lumbar puncture syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
POST LUMBAR PUNCTURE SYNDROME is moderately reported among NUSINERSEN users, representing a notable but not dominant share of adverse events.
In addition to post lumbar puncture syndrome, the following adverse reactions have been reported for NUSINERSEN:
POST LUMBAR PUNCTURE SYNDROME has been reported as an adverse event in 502 FDA reports for NUSINERSEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
POST LUMBAR PUNCTURE SYNDROME accounts for approximately 5.2% of all adverse event reports for NUSINERSEN, making it one of the most commonly reported side effect.
If you experience post lumbar puncture syndrome while taking NUSINERSEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.